WELCOME & INTRODUCTIONS |
| 07:45 | Chairman's Welcome & Framing of Theme |
|---|
| | Laurence Klotz, MD | Canada |
| | |
| SESSION ONE | LOCALIZED PROSTATE CANCER |
|---|
| | Co-Moderators: Hashim Ahmed & Bertrand Tombal |
| | |
| 07:55 | International Perspectives on Prostate Cancer Screening |
|---|
| | Yoshiyuki Kakehi, MD | Japan |
| | |
| 08:10 | Have Molecular Markers Changed the Management of Localized Prostate Cancer? |
|---|
| | Peter Carroll, MD | USA |
| | |
| 08:25 | Role of Statins, Metformin and Exercise in Prostate Cancer Prevention |
|---|
| | Matthew Cooperberg, MD | USA |
| | |
| 08:40 | DISCUSSION |
|---|
| | |
| 08:50 | How to Measure Effectiveness of Focal Therapy |
|---|
| | Philipp Dahm, MD | USA |
| | |
| 09:05 | Focal Therapy! The New Snake Oil Medicine |
|---|
| | Over treatment for Indolent Disease & Under treatment for Aggressive Disease |
| | Henk van der Poel, MD | Netherlands |
| | |
| 09:20 | Focal Therapy - Where is it Headed? |
|---|
| | Mark Emberton, MD | England |
| | |
| 09:35 | DISCUSSION |
|---|
| | |
| SESSION TWO | PROSTATE CANCER |
|---|
| | Co-Moderators: Greg Boustead & Nathan Lawrentscuk |
| | |
| 09:45 | Rationale for Metformin in Prostate Cancer |
|---|
| | Neil Fleshner, MD | Canada |
| | |
| 10:00 | Template Versus Targeted Biopsy |
|---|
| | Hashim Ahmed, MD | England |
| | |
| 10:15 | MRI imaging |
|---|
| | Arnaud Villers, MD | France |
| | |
| 10:30 | DISCUSSION |
|---|
| | |
| 10:40 | Da Vinci Robot for the Developing World: A Wasteful Trend or a Worthwhile Technology? |
|---|
| | Peter Hammerer, MD | Germany |
| | |
| 10:50 | The Non-Western World Should Embrace the Robot |
|---|
| | Shin Egawa, MD | Japan |
| | |
| 11:00 | Robotics - A Skeptical View from the Developing World |
|---|
| | Arturo Mendoza-Valdés, MD | Mexico |
| | |
| 11:10 | DISCUSSION |
|---|
| | |
| 11:20 | Intermittent ADT |
|---|
| | Bertrand Tombal | Belgium |
| | |
| 11:35 | Management of Biochemical Failure - Role of Surgical Resection |
|---|
| | Hendrik Van Poppel, MD | Belgium |
| | |
| 11:50 | DISCUSSION |
|---|
| | |
| SESSION THREE | A CLINICAL CASE IN PROSTATE CANCER |
|---|
| | Co-Moderators: Roger Kirby & Laurence Klotz |
| | |
| 12:00 | International Perspectives on Clinical Management of Prostate Cancer |
|---|
| | Four (5 minute) clinical case presentations justifying each approach followed by a 15 minute open discussion |
| | CASE: 61 year old healthy man with PSA 20, Gleason 8 T2b prostate cancer |
| | PRESENTATIONS: |
| | Mack Roach, MD | USA (5 min): |
| | Mahesh Desai, MD | India (5min): |
| | Axel Heidenriech, MD | Germany (5 min): |
| | Scott Eggener, MD | USA (5 min): |
| | |
| 12:20 | DISCUSSION |
|---|
| | |
| 12:35 | BREAK & LUNCH SERVICE: |
|---|
| | (All Attendees: pick up lunch and return to seats for Session Four Working Lunch Session) |
| | |
| SESSION FOUR | A PROVOCATIVE DISCUSSION |
|---|
| | Co-Moderators: Roger Kirby & Laurence Klotz |
| | |
| 13:00 | MAJOR OBSERVATIONS: |
|---|
| | Objectives: Four Key Opinion Leaders will identify the single most major observation in their field within the last 3 years. Each presenter will have 4 minutes to describe their observation, 4 minutes to put this into context and 4 minutes to receive comments by the Critique Panel. Critique Panel: Manfred Wirth, Philipp Dahm, Thomas Keane, - |
| |
Observation #1: Gerry Andriole (Prostate) |
| | Observation #2: Christian Steif (Prostate) |
| | Observation #3: Peter Mulders (Kidney) |
| | Observation #4: Sharokh Shariat (Upper Tract Urothelial Carcinoma) |
| | |
| SESSION FIVE | BLADDER CANCER |
|---|
| | Moderator: Laurence Klotz |
| | |
| 13:50 | POLAND: Bladder Cancer Prevention Update |
|---|
| | Roman Sosnowski, MD | Poland |
| | |
| 14:00 | ITALY: Bladder Cancer Prevention Update |
|---|
| | Maurizio Brausi, MD | Italy |
| | |
| 14:10 | Enhanced Bladder Tumor Visualization Techniques: |
|---|
| | Are They Worth It and Do They Have a Role? |
| | Theo de Reijke, MD | Netherlands |
| | |
| 14:20 | DISCUSSION |
|---|
| | |
| SESSION SIX | RENAL CANCER |
|---|
| | Moderators: R.Houston Thompson & Ofer Yossepowitch |
| | |
| 14:25 | Partial Nephrectomy in the Elderly: Is it worth the increased risk of complications? |
|---|
| | Bradley Leibovich, MD | USA |
| | |
| 14:35 | Focal Therapy for Renal Cancer |
|---|
| | Damien Bolton, MD | Australia |
| | |
| 14:45 | Lessons from the Nephrectomy Outcomes Data |
|---|
| | Adrian Joyce, MD | England |
| | |
| 14:55 | The Role of lymph node dissection in RCC |
|---|
| | Christopher Wood, MD | USA |
| | |
| 15:05 | DISCUSSION |
|---|
| | |
| SESSION SEVEN | DEBATE: TESTOSTERONE REPLACEMENT | Fool’s Paradise or Elixir of Youth? |
|---|
| | Moderator: Peter Hammerer |
| | |
| 15:10 | Argument For | Testosterone Replacement is Safe |
|---|
| | Larry Goldenberg, MD | Canada |
| | |
| 15:20 | Argument Against | Safety is Unproven |
|---|
| | Laurence Klotz, MD | Canada |
| | |
| 15:30 | DISCUSSION |
|---|
| | |
| 15:45 | Adjourn |
|---|
| | Laurence Klotz, MD | Canada |
| | |
